A Phase I Trial of Pox PSA vaccines (PROSTVAC<sup>®</sup>-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer

A Phase I Trial of Pox PSA vaccines (PROSTVAC<sup>®</sup>-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer

<p>Abstract</p> <p>Purpose</p> <p>Based on previous studies that demonstrated the safety profile and preliminary clinical activity of prostate specific antigen (PSA) targeted therapeutic vaccines, as well as recent laboratory data supporting the value of the addition of...

Full description

Bibliographic Details
Main Authors: Lattime E, Israeli R, Petrylak DP, Kaufman H, Plante M, DiPaola RS, Manson K, Schuetz T
Format: Article
Language:English
Published: BMC 2006-01-01
Series:Journal of Translational Medicine
Subjects:
PSA
Prostate specific antigen
vaccine
co-stimulatory molecules
Online Access:http://www.translational-medicine.com/content/4/1/1

Internet

http://www.translational-medicine.com/content/4/1/1

Similar Items